Thermo-Responsive, Inflammation-Targeting (TRIT) Hydrogel Formulations for Local Drug Delivery in Intestinal Inflammation

This technology introduces innovative solutions for targeted drug delivery, particularly focusing on thermoresponsive hydrogel polymers. These formulations incorporate thermoresponsive hydrogel polymers containing releasable therapeutic agents, offering a unique blend of characteristics, including mechanical strength, biocompatibility, thermal responsiveness, and precise drug delivery configurations. The compositions can include a sol-to-gel transition system under physiological conditions, comprising nanoparticles and thermoresponsive polymers with attached ligands. In the medical context, this technology addresses the need for improved drug delivery in conditions such as Ulcerative Colitis, ensuring more effective and precise treatment.

Researchers

Robert Langer / Joshua Korzenik / Ashok Kakkar / Sufeng Zhang / Giovanni Traverso

Departments: Office of the Institute Professors, David H Koch Institute for Integrative Cancer Res, Department of Mechanical Engineering
Technology Areas: Chemicals & Materials: Polymers / Drug Delivery: Microparticles & Nanoparticles
Impact Areas: Healthy Living

  • compositions and related methods for targeted drug delivery
    United States of America | Granted | 11,684,583

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies